Cathie's Ark Logo
undefined Logo

ARKK Holdings of Verve Therapeutics (VERV) - Updated Daily

Gene TherapyGenomicsCRSPR Gene Editing
Morning Brew Icon
China's One Ocean Problem
Date
Direction
Shares
Fund Weight
Fund
May 15, 2024
SELL68.627k0.0066%ARKK
May 14, 2024
SELL109.274k0.0109%ARKK
May 10, 2024
SELL3.275k0.0003%ARKK
May 9, 2024
SELL306.104k0.03%ARKK
February 13, 2024
BUY29.618k0.0042%ARKK

Key Statistics

⚖️Weighting🧢Market Cap
0.2%$535.70m
🏋🏿‍♂️Weight Rank In ARKK🌏Country
35🇺🇸United States
🏋️‍♀️Weight Rank Across All Funds💳ARK Estimated Cost Average
60$28.17
🎫ARK Ownership Percent
2.5%

Other ETFs That Hold VERV

Ticker
NameWeight
ARKGARK Genomic Revolution ETF2.46%
GNOMGlobal X Genomics & Biotechnology ETF1.1%
XBISPDR® S&P Biotech ETF0.82%
ARKKARK Innovation ETF0.36%
LABUS&P Biotech Bull 3X Shares ETF0.124%
IBBiShares Biotechnology ETF0.07%

Research Notes and Commentary for VERV

No Research Notes Found for VERV